Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-464

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 464 52 Master Bottle Label Approval Rev A 10 20)

Label for Atorvastatin Calcium Tablets, USP 20 mg, film-coated oral tablets. The package contains 30 tablets labeled for prescription use only. Storage instructions specify 20°-25°C (68°-77°F). Manufactured and repackaged by Northwind Pharmaceuticals, Indianapolis, IN. Includes batch and expiration data.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line chart depicting cumulative incidence percentages over time in years comparing Atorvastatin and placebo groups. The chart shows a lower cumulative incidence for Atorvastatin compared to placebo, with a hazard ratio (HR) of 0.64 and a p-value of 0.0005.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph displaying cumulative hazard (%) over time (years) up to 5 years, comparing Atorvastatin and Placebo groups. The Atorvastatin group shows a lower cumulative hazard relative to Placebo. The graph includes hazard ratio (HR 0.63) with 95% confidence interval (0.48-0.83) and a p-value of 0.001, depicting comparative risk of primary endpoints over four years of follow-up.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing subjects (%) experiencing an event over time (years) to first major cardiovascular endpoint comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The graph includes a hazard ratio (HR) of 0.78 (0.69-0.89) with P=0.0002, indicating statistical data on event occurrence rates between the two dosages over a 5-year period.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, and the calcium ion complex with hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.